The mutation of various phosphorylation sites in GSK3B was identified in cell nuclei of prostate cancer tissue samples and contributed to prostate cancer progression by increasing protein kinase B/Akt and Akt activity [41]. Here, GSK3B is linked to prostate carcinoma.